Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.985
Filter
1.
BMC Womens Health ; 24(1): 503, 2024 Sep 11.
Article in English | MEDLINE | ID: mdl-39261782

ABSTRACT

BACKGROUND: This study aimed to determine the prevalence of chronic pelvic pain(CPP) in refugee and non-refugee women, determine the factors associated with CPP, and evaluate the effect of CPP on life quality. METHODS: This was a cross-sectional study conducted among 283 non-refugee and 278 refugee women in Turkey. A questionnaire including questions assessing chronic pelvic pain and related factors, World Health Organization Quality of Life Scale Short Form(WHOQOL-BREF), Depression Anxiety Stress Scale-21, were administered to the participants. Chi-square test, Mann-Whitney U test and multiple logistic regression analysis were used for statistical analysis. RESULTS: The prevalence of chronic pelvic pain was 41.0% in refugee women and 19.1% in non-refugee women (p< 0.001). The prevalence of CPP was 1.68 times higher in refugee women than in non-refugee women (OR;95%CI:1.68;1.01-2.81). In the multivariate analysis performed in the study group, refugee status, low family income status(OR;95%CI:2.09;1.26-3.46), low back pain(OR;95%CI:2.02;1.21-3.35), dyspareunia (OR; 95%CI:2.96;1.75-4.99), number of three or more miscarriages (OR;95%CI:3.07;1.18-8.01), history of gynaecological surgery (OR;95%CI:2.44;1.33-4.50), diarrhea (OR;95%CI:2.01;1.07-3.76), urinary tract infections(OR; 95%CI:1.66;1.02-2.71) and anxiety(OR; 95%CI:1.17;1.10-1.24) were found to be risk factors for CPP. In the refugee and non-refugee groups, those with CPP had lower scores in all subdomains of the WHOQOL-BREF scale than those without CPP (p < 0.05). CONCLUSIONS: Refugee status independently contributes to the risk of developing CPP. Targeted interventions to address CPP and its associated risk factors are needed, particularly in vulnerable refugee populations, to improve their quality of life.


Subject(s)
Chronic Pain , Pelvic Pain , Quality of Life , Refugees , Humans , Female , Quality of Life/psychology , Pelvic Pain/psychology , Pelvic Pain/epidemiology , Pelvic Pain/etiology , Adult , Refugees/psychology , Refugees/statistics & numerical data , Cross-Sectional Studies , Chronic Pain/psychology , Chronic Pain/epidemiology , Turkey/epidemiology , Risk Factors , Prevalence , Surveys and Questionnaires , Middle Aged , Young Adult , Depression/epidemiology , Depression/psychology , Anxiety/epidemiology , Anxiety/psychology
3.
Scand J Pain ; 24(1)2024 Jan 01.
Article in English | MEDLINE | ID: mdl-39253953

ABSTRACT

OBJECTIVES: A high incidence of attention-deficit hyperactivity disorder (ADHD) has been reported in chronic pain (ChP) patients. Furthermore, an association between ChP and muscular dysregulation has been reported in adults with ADHD. The present study investigated whether ADHD was more prevalent among psychiatric outpatients with ChP than those without ChP, and if there was an association between ChP, muscular dysregulation and characteristics of pain in patients with ADHD. METHODS: One-hundred and twenty-one individuals remitted to an outpatient psychiatry unit took part in this naturalistic epidemiological cross-sectional study. They were assessed with a pain self-report form (localization, intensity, and onset) and a test of muscle dysregulation (the Motor Function Neurological Assessment). Prevalence of ADHD among patients with ChP, as well as the qualitative characteristics of ChP within the ADHDgroup are reported. Both ChP and pain intensity correlated with muscular dysregulation through Spearman's rho analysis. Additionally, the relationship between various diagnostic categories (ADHD, affective disorders, anxiety, or personality disorders) and incidence of axial pain was evaluated in logistic regression. RESULTS: ADHD was significantly more prevalent in patients with ChP, than in patients without ChP. In the ADHD group, ChP and pain intensity was associated with muscular dysregulation, particularly with high muscle tone. ChP was more axial and widespread, than for the patients without ADHD, and started at an early age. ADHD diagnosis predicted axial pain, whereas affective-, anxiety-, or personality disorders did not. CONCLUSIONS: The study suggests that ChP in ADHD is associated with muscular dysregulation and is qualitatively different from ChP in psychiatric patients without ADHD. These findings may lead to further understanding of potential mechanisms involved in ADHD and ChP, and in turn to new treatment strategies for both disorders.


Subject(s)
Attention Deficit Disorder with Hyperactivity , Chronic Pain , Humans , Attention Deficit Disorder with Hyperactivity/physiopathology , Attention Deficit Disorder with Hyperactivity/epidemiology , Chronic Pain/physiopathology , Chronic Pain/epidemiology , Male , Female , Cross-Sectional Studies , Adult , Middle Aged , Prevalence , Pain Measurement , Young Adult
4.
Medicine (Baltimore) ; 103(37): e39301, 2024 Sep 13.
Article in English | MEDLINE | ID: mdl-39287318

ABSTRACT

Educational attainment (EA) is often used as a symbol of socioeconomic status and is associated with several diseases. However, uncertainty remains regarding the potential relationship between EA and chronic pain. This study aimed to evaluate the potential causal association between EA and chronic pain. The primary method employed in Mendelian randomization (MR) analysis was inverse-variance weighted method. Additionally, MR-Egger intercept, Cochran Q, and MR-PRESSO statistical analyses were conducted to assess potential pleiotropy and heterogeneity. The MR analysis provided evidence that genetically predicted additional education significantly reduced the risk of chronic pain. Specifically, this genetic factor may reduce multisite chronic pain by 27.6%, and chronic widespread pain by 3.8%. The results of sensitivity analysis indicated the reliability of our causal estimates. Higher levels of EA may provide protection against chronic pain risk. Enhancing education, narrowing social and economic disparities may help alleviate the burden of chronic pain.


Subject(s)
Chronic Pain , Educational Status , Mendelian Randomization Analysis , Humans , Chronic Pain/genetics , Chronic Pain/epidemiology , Causality
5.
Sci Rep ; 14(1): 20751, 2024 09 05.
Article in English | MEDLINE | ID: mdl-39237574

ABSTRACT

Chronic diseases and pain exacerbate depressive symptom in Syria. Limited research on hospital-induced depressive symptom among Syrian patients with chronic diseases warrants further study. A cross-sectional study in four Damascus hospitals revealed high rates of pain and depressive symptom. This study aims to investigate the prevalence and severity of chronic pain and hospital-induced depressive symptom in Syrian patients, as well as the relationship between pain, depressive symptom, and medication behavior. This study analyzes the impact of pain, hospitalization, and medication on patients with chronic diseases. The four Damascus hospitals included 453 patients from various departments. Data were collected through structured interviews and internationally recognized scales such as the PSEQ, HADS, and MMAS. These findings offer insights into pain management and psychological well-being, with implications for patient care and support strategies. The study involved 453 patients with chronic diseases, with gender distribution showing 46.6% females and 53.4% males. The age range was from 7 to 87 years, with an average of 46.87 years. Chi-square tests revealed a significant connection between gender and HADS-A scores, where 48.3% of females had abnormalities (χ2 (1, N = 453) = 7.125, p = 0.028). Marital status was significantly associated with anxiety and depressive symptom levels, particularly among widowed and divorced patients. Employment status, education, and comorbidity were linked to abnormal HADS-A scores, while education level showed a positive correlation with HADS-D scores. ANOVA tests showed significant differences in MMAS scores across income groups (F (3, 449) = 3.167, p = 0.024), with a notable difference between low-income and lower-middle-income groups (mean difference = 0.389, p = 0.031. Chronic pain and HID are prevalent among Syrian patients with chronic diseases and influenced by socio-demographic factors. Personalized interventions are needed to address psychological symptoms and medication behavior.


Subject(s)
Depression , Hospitalization , Humans , Male , Female , Middle Aged , Syria/epidemiology , Adult , Depression/epidemiology , Aged , Cross-Sectional Studies , Adolescent , Chronic Disease , Young Adult , Aged, 80 and over , Chronic Pain/drug therapy , Chronic Pain/epidemiology , Chronic Pain/psychology , Child , Prevalence
6.
Health Promot Chronic Dis Prev Can ; 44(7-8): 306-318, 2024 Aug.
Article in English, French | MEDLINE | ID: mdl-39141614

ABSTRACT

INTRODUCTION: Multiple Canadian jurisdictions have reported a pattern of chronic pain among people who died from substance-related acute toxicity. This study examined the prevalence and characteristics of those with chronic pain using data from a national study of people who died of accidental acute toxicity. METHODS: A cross-sectional analysis of accidental substance-related acute toxicity deaths that occurred in Canada between 1 January 2016 and 31 December 2017 was conducted. The prevalence of pain and pain-related conditions were summarized as counts and percentages of the overall sample. Subgroups of people with and without a documented history of chronic pain were compared across sociodemographic characteristics, health history, contextual factors and substances involved. RESULTS: From the overall sample (n = 7902), 1056 (13%) people had a history of chronic pain while 6366 (81%) had no documented history. Those with chronic pain tended to be older (40 years and older), unemployed, retired and/or receiving disability supports around the time of death. History of mental health conditions, trauma and surgery or injury was significantly more prevalent among people with chronic pain. Of the substances that most frequently contributed to death, opioids typically prescribed for pain (hydromorphone and oxycodone) were detected in toxicology more often among those with chronic pain than those without. CONCLUSION: Findings underscore the cross-cutting role of multiple comorbidities and unmanaged pain, which could compound the risk of acute toxicity death. Continued prioritization of harm reduction and regular patient engagement to assess ongoing needs are among the various opportunities for intervention.


Subject(s)
Chronic Pain , Humans , Canada/epidemiology , Male , Female , Chronic Pain/epidemiology , Cross-Sectional Studies , Middle Aged , Adult , Aged , Prevalence , Analgesics, Opioid/poisoning , Adolescent , Young Adult , Age Factors , Drug Overdose/mortality , Drug Overdose/epidemiology , Sociodemographic Factors
7.
Sci Rep ; 14(1): 19196, 2024 08 19.
Article in English | MEDLINE | ID: mdl-39160256

ABSTRACT

The COVID-19 pandemic has increased germ aversion, an aversive affective response to a high likelihood of pathogen transmission. While psychological factors are associated with chronic pain, the relationship between germ aversion and chronic pain remains unexplored. This study aimed to examine the relationship between germ aversion and new-onset and prognosis of chronic pain using longitudinal data collected during the COVID-19 pandemic. We conducted web-based surveys of full-time workers at baseline and after three months. Data were collected on demographic characteristics, psychological factors, and chronic pain. Germ aversion was assessed using a modified Perceived Vulnerability to Disease scale. We analyzed responses from 1265 panelists who completed the survey twice. The prevalence of chronic low back pain (CLBP) and chronic neck and shoulder pain (CNSP) was associated with sex, short sleep duration, psychological distress, loneliness, and germ aversion. Stratified analyses showed that germ aversion was a risk factor for CLBP at three months in both individuals with and without CLBP at baseline, and for CNSP at three months in those with CNSP at baseline, even after adjustment for confounders. In conclusion, this preliminary study suggests that high germ aversion is a risk factor for CLBP and CNSP in young and middle-aged workers.


Subject(s)
COVID-19 , Low Back Pain , Shoulder Pain , Humans , COVID-19/psychology , COVID-19/epidemiology , Male , Female , Low Back Pain/psychology , Low Back Pain/epidemiology , Adult , Risk Factors , Middle Aged , Shoulder Pain/epidemiology , Shoulder Pain/psychology , Chronic Pain/psychology , Chronic Pain/epidemiology , Internet , SARS-CoV-2/isolation & purification , Surveys and Questionnaires , Pandemics , Longitudinal Studies , Prevalence , Young Adult
8.
BMC Surg ; 24(1): 222, 2024 Aug 05.
Article in English | MEDLINE | ID: mdl-39103814

ABSTRACT

OBJECTIVE: To assess the effectiveness of a modified Lichtenstein Repair combined with Herniorrhaphy in reducing postoperative chronic pain and enhancing recovery and quality of life in inguinal hernia patients. METHODS: This retrospective study, conducted at the Taleghani training center between January 2021 and February 2023, retrospectively examined 289 hernia surgeries, of which 130 employed a modified Lichtenstein technique. The investigation encompassed a detailed analysis of patient demographics, employed surgical techniques, operative methods with a focus on minimal dissection, and an evaluation of postoperative outcomes. RESULTS: In this study of 289 participants, primarily males aged 60-80 years, the modified technique group demonstrated a notably lower incidence of hernia recurrence (1.5%) compared to the Lichtenstein group (3.1%). Additionally, the modified technique was more effective in reducing postoperative pain, with a significantly lower mean Visual Analogue Scale (VAS) score of 0.15, compared to 0.31 in the Lichtenstein group. This suggests enhanced patient comfort and a potentially quicker recovery in the modified technique group. CONCLUSION: The modified Lichtenstein hernioplasty technique, characterized by minimal tissue trauma and precise mesh placement, emerges as an effective approach in inguinal hernia repair. It offers significant benefits in reducing postoperative discomfort and chronic pain, thereby enhancing patient recovery and overall quality of life. This method aligns with current surgical trends towards patient-centric and minimally invasive procedures.


Subject(s)
Chronic Pain , Hernia, Inguinal , Herniorrhaphy , Pain, Postoperative , Quality of Life , Surgical Mesh , Humans , Male , Retrospective Studies , Middle Aged , Aged , Herniorrhaphy/methods , Hernia, Inguinal/surgery , Female , Chronic Pain/etiology , Chronic Pain/epidemiology , Chronic Pain/prevention & control , Aged, 80 and over , Pain, Postoperative/etiology , Pain, Postoperative/prevention & control , Pain, Postoperative/epidemiology , Adult , Treatment Outcome , Recurrence , Pain Measurement
9.
BMC Psychol ; 12(1): 451, 2024 Aug 23.
Article in English | MEDLINE | ID: mdl-39180131

ABSTRACT

BACKGROUND: Problematic anger, characterized by excessive frequency, intensity, and duration of anger which causes substantial emotional distress and functional interference, poses a marked challenge in military populations. Despite its importance, research on this topic is limited. This study contributes to the literature by exploring problematic anger in a large sample of Norwegian military personnel who served in NATO missions in Afghanistan. METHODS: All Norwegian military personnel who deployed to Afghanistan between 2001 and 2020 were sent a link to a cross-sectional web-based survey by the Joint Medical Services of the Norwegian Armed Forces in 2020. A total of 6205 individuals (response rate: 67.7%) participated. The cross-sectional survey assessed problematic anger, mental and physical health, war zone stressor exposure, and quality of life. RESULTS: Overall, 8.4% of participants reported problematic anger. Mental health disorders, deployment-related shame and guilt, chronic pain, and challenges with the military-to-civilian transition were independently associated with problematic anger. Both staying in service and maintaining a part-time connection with the military as a reservist mitigated the risk of problematic anger after deployment, compared to complete separation from military service. CONCLUSION: Findings demonstrate a sizeable prevalence of problematic anger among veterans of combat deployments. Given the associations between problematic anger and mental health disorders, chronic pain, and transition challenges, interventions designed to mitigate problematic anger need to be multi-faceted, including the possibility of maintaining an ongoing connection to military service. By reducing the risk of problematic anger, occupational, interpersonal and health outcomes may be improved for service members. Future research should examine the impact of problematic anger on adjustment over time, prevention strategies, and problematic anger in other high-risk occupations.


Subject(s)
Afghan Campaign 2001- , Anger , Military Deployment , Military Personnel , Humans , Male , Military Personnel/psychology , Military Personnel/statistics & numerical data , Adult , Female , Cross-Sectional Studies , Prevalence , Norway/epidemiology , Risk Factors , Military Deployment/psychology , Military Deployment/statistics & numerical data , Young Adult , Mental Disorders/epidemiology , Mental Disorders/psychology , Quality of Life/psychology , Guilt , Chronic Pain/psychology , Chronic Pain/epidemiology , Shame , Middle Aged
10.
Medicine (Baltimore) ; 103(32): e39113, 2024 Aug 09.
Article in English | MEDLINE | ID: mdl-39121265

ABSTRACT

Insomnia can coexist with chronic pain and is a major cause of rapidly increasing medical expenses. However, insomnia has not been fully evaluated in patients with chronic pain. This retrospective study aimed to identify the risk factors for insomnia in patients with chronic non-cancer pain. A total of 301 patients with chronic non-cancer pain were enrolled. Patients with the Athens insomnia scale scores ≥ 6 and < 6 were classified into insomnia (+) and insomnia (-) groups, respectively. All patients completed self-report questionnaires as part of their chronic pain treatment approach. Univariate and multivariate analyses were performed to predict insomnia. We found that 219 of 301 (72.8%) patients met the AIS criteria for insomnia. Significant differences were depicted between patients with and without insomnia in terms of body mass index, numeric rating scale, pain catastrophizing scale, hospital anxiety, and depression scale (HADS), pain disability assessment scale, EuroQol 5 dimension (EQ5D), and pain self-efficacy questionnaire. Multiple regression analysis identified the numeric rating scale, HADS, and EQ5D scores as factors related to insomnia in patients with chronic non-cancer pain. Anxiety, depression, and disability were associated with a greater tendency toward insomnia. HADS and EQ5D scores are useful screening tools for preventing insomnia in patients with chronic non-cancer pain.


Subject(s)
Chronic Pain , Sleep Initiation and Maintenance Disorders , Humans , Sleep Initiation and Maintenance Disorders/epidemiology , Sleep Initiation and Maintenance Disorders/psychology , Male , Retrospective Studies , Female , Chronic Pain/psychology , Chronic Pain/epidemiology , Middle Aged , Risk Factors , Adult , Aged , Pain Measurement/methods , Depression/epidemiology , Surveys and Questionnaires , Anxiety/epidemiology , Catastrophization/psychology
11.
BMC Pediatr ; 24(1): 508, 2024 Aug 08.
Article in English | MEDLINE | ID: mdl-39112922

ABSTRACT

BACKGROUND: Pediatric chronic pain (i.e., pain lasting ≥ 3 months) is prevalent, disabling, and costly. It spikes in adolescence, interrupts psychosocial development and functioning, and often co-occurs with mental health problems. Chronic pain often begins spontaneously without prior injuries and/or other disorders. Prospective longitudinal cohort studies following children from early childhood, prior to chronic pain onset, are needed to examine contributing factors, such as early pain experiences and mental health. Using data from a longitudinal community pregnancy cohort (All Our Families; AOF), the present study examined the associations between early developmental risk factors, including early childhood pain experiences and mental health symptoms, and the onset of pediatric chronic pain at ages 8 and 11 years. METHODS: Available longitudinal AOF data from child age 4 months, as well as 1, 2, 3, 5, 8, and 11 years, were used. Mothers reported their child's pain experiences (e.g., hospitalizations, vaccinations, gut problems) at each timepoint from 4 months to 8 years, child chronic pain at age 8, and child mental health symptoms at ages 5 and 8 years. Children reported their chronic pain frequency and interference at age 11. Adaptive least absolute shrinkage and selection operator (LASSO) regressions were used to select predictor variables. Complete case analyses were complemented by multiple imputation using chained equation (MICE) models. RESULTS: Gut problems, emergency room visits, frequent pain complaints, and headaches at age 5 or earlier, as well as female sex, were associated with increased risk of maternal reported child chronic pain at age 8. Maternal reported chronic pain at age 8 was associated with higher levels of child-reported pain frequency and pain interferences at age 11. Boys self-reported lower levels of pain interference at age 11. CONCLUSIONS: Some, but not all, painful experiences (e.g., gut problems, ER visits, pain complaints) in early life contribute to pediatric chronic pain onset and should be considered for screening and early intervention.


Subject(s)
Chronic Pain , Humans , Chronic Pain/epidemiology , Chronic Pain/psychology , Chronic Pain/etiology , Child , Risk Factors , Female , Male , Longitudinal Studies , Child, Preschool , Infant , Prospective Studies
12.
J Cardiothorac Vasc Anesth ; 38(2): 490-498, 2024 Feb.
Article in English | MEDLINE | ID: mdl-39093584

ABSTRACT

OBJECTIVE: Thoracic surgery is associated with one of the highest rates of chronic postsurgical pain (CPSP) among all surgical subtypes. Chronic postsurgical pain carries significant medical, psychological, and economic consequences, and further interventions are needed to prevent its development. This study aimed to determine the prevalence, characteristics, and risk factors associated with CPSP after thoracic surgery. DESIGN: A prospective cohort study. SETTING: Single-center tertiary care hospital. PARTICIPANTS: This study included 285 adult patients who underwent thoracic surgery at Toronto General Hospital in Toronto, Canada, between 2012 and 2020. MEASUREMENTS AND MAIN RESULTS: Demographic, psychological, and clinical data were collected perioperatively, and follow-up evaluations were administered at 3, 6, and 12 months after surgery to assess CPSP. Chronic postsurgical pain was reported in 32.4%, 25.4%, and 18.2% of patients at 3, 6, and 12 months postoperatively, respectively. Average CPSP pain intensity was rated to be 3.37 (SD 1.82) at 3 months. Features of neuropathic pain were present in 48.7% of patients with CPSP at 3 months and 71% at 1 year. Multivariate logistic regression models indicated that independent predictors for CPSP at 3 months were scores on the Hospital Anxiety and Depression Scale (adjusted odds ratio [aOR] of 1.07, 95% CI of 1.02 to 1.14, p = 0.012) and acute postoperative pain (aOR of 2.75, 95% CI of 1.19 to 6.36, p = 0.018). INTERVENTIONS: None. CONCLUSIONS: Approximately 1 in 3 patients will continue to have pain at 3 months after surgery, with a large proportion reporting neuropathic features. Risk factors for pain at 3 months may include preoperative anxiety and depression and acute postoperative pain.


Subject(s)
Chronic Pain , Pain, Postoperative , Thoracic Surgical Procedures , Humans , Male , Female , Prospective Studies , Pain, Postoperative/epidemiology , Pain, Postoperative/psychology , Pain, Postoperative/etiology , Pain, Postoperative/diagnosis , Risk Factors , Chronic Pain/epidemiology , Chronic Pain/etiology , Chronic Pain/psychology , Middle Aged , Prevalence , Thoracic Surgical Procedures/adverse effects , Aged , Cohort Studies , Adult , Follow-Up Studies
13.
N Z Med J ; 137(1601): 36-47, 2024 Aug 23.
Article in English | MEDLINE | ID: mdl-39173160

ABSTRACT

AIMS: Post mastectomy pain syndrome (PMPS) can have significant negative effects on patients' quality of life after mastectomy. The estimated prevalence of PMPS varies widely and there is little data from a New Zealand population. This limits clinicians' ability to meaningfully describe and discuss pain-related complications of mastectomy peri-operatively. METHOD: We designed a single-centre, retrospective study to describe acute post-operative analgesic requirements after mastectomy, to describe the prevalence of PMPS at least 1 year after surgery, and to identify associated risk factors for this complication. RESULTS: One hundred and thirty mastectomy patients met inclusion criteria and 59 were willing and able to participate in 12-month follow-up. Acute post-operative pain was generally well managed with modest doses of oral analgesics. Sixty-six percent (n=39) of women reported some form of persistent pain symptoms post-mastectomy; this was associated with younger age, axillary surgery and chemotherapy. Only 5% of patients (n=3) met consensus criteria for PMPS, which limited identification of risk factors for this more severe complication. CONCLUSION: Despite PMPS occurring infrequently, post-operative pain of a less severe nature after mastectomy occurs commonly. Clinicians should remain vigilant to possible risk factors for this post-operative complication and counsel patients appropriately.


Subject(s)
Breast Neoplasms , Mastectomy , Pain, Postoperative , Tertiary Care Centers , Humans , Female , Pain, Postoperative/drug therapy , Pain, Postoperative/epidemiology , Pain, Postoperative/etiology , Mastectomy/adverse effects , Middle Aged , Retrospective Studies , Adult , Aged , Breast Neoplasms/surgery , Risk Factors , Analgesics/therapeutic use , New Zealand/epidemiology , Acute Pain/etiology , Acute Pain/drug therapy , Acute Pain/epidemiology , Prevalence , Chronic Pain/epidemiology , Chronic Pain/etiology , Chronic Pain/drug therapy , Pain Measurement
14.
Behav Ther ; 55(5): 1015-1025, 2024 Sep.
Article in English | MEDLINE | ID: mdl-39174262

ABSTRACT

Pain, substance use, and mental health conditions are common among people living with HIV (PLWH), and avoidance and rumination may influence the co-occurrence of these conditions. The present study examined longitudinal associations between avoidance/rumination and pain outcomes, anxiety, anger, and substance use among PLWH. Participants (N = 187) with chronic pain and depressive symptoms completed self-report assessments over a 1-year period. Greater avoidance/rumination was positively associated with mental health outcomes (anxiety, anger), pain interference, and alcohol use across participants after controlling for depression severity. At time points with greater avoidance/rumination than average, participants also reported increased pain severity and interference, anxiety and anger symptoms, and alcohol use. No associations were found between avoidance/rumination and cannabis use. Results suggest a mechanistic effect of avoidance/rumination, such that increases in avoidance/rumination correspond with poorer health outcomes among PLWH over time. Targeting avoidance/rumination through intervention approaches may be beneficial for addressing comorbid health conditions among PLWH. Additional research is necessary to investigate this possibility and further characterize the effects of avoidance/rumination on health outcomes for PLWH.


Subject(s)
Anxiety , Depression , HIV Infections , Mental Health , Rumination, Cognitive , Substance-Related Disorders , Humans , Male , Female , HIV Infections/psychology , HIV Infections/complications , HIV Infections/epidemiology , Substance-Related Disorders/psychology , Substance-Related Disorders/epidemiology , Substance-Related Disorders/complications , Middle Aged , Depression/psychology , Depression/epidemiology , Depression/complications , Adult , Anxiety/psychology , Anxiety/epidemiology , Mental Health/statistics & numerical data , Chronic Pain/psychology , Chronic Pain/epidemiology , Anger , Avoidance Learning , Self Report
15.
BMC Geriatr ; 24(1): 674, 2024 Aug 10.
Article in English | MEDLINE | ID: mdl-39127641

ABSTRACT

BACKGROUND: Calf circumference is currently recommended as a case-finding marker for sarcopenia, but its usefulness has not been determined in chronic pain conditions. Therefore, the present study aimed to evaluate the predictive performance of calf circumference in diagnosing sarcopenia in older patients with chronic low back pain. METHODS: Ambulatory adult patients aged ≥ 65 years with chronic low back pain were enrolled. A diagnosis of sarcopenia was established based on the criteria outlined by the Asian Working Group for Sarcopenia in 2019. Patient demographics, pain-related factors, clinical factors, and sarcopenia-related measurements were compared between non-sarcopenic and sarcopenic patients. Linear regression analysis was used to evaluate the correlation of calf circumference with muscle mass, strength, and physical performance. Also, a receiver operating characteristic curve analysis for calf circumference in predicting sarcopenia was conducted; and area under the curve (AUC) values, along with their corresponding 95% confidence intervals (CI), were calculated. RESULTS: Data from 592 patients were included in the analysis. Eighty-five patients were diagnosed with sarcopenia (14.3%), 71 of whom had severe sarcopenia (11.9%). A higher prevalence of sarcopenia was observed in female patients (9.0% vs. 16.7%, p = 0.016). After adjusting for age, BMI, and comorbidities, calf circumference correlated positively with muscle mass but not with muscle strength and physical performance. The AUC values for sarcopenia were 0.754 (95% CI = 0.636-0.871, p = 0.001) in males and 0.721 (95% CI = 0.657-0.786, p < 0.001) in females. The cut-offs for calf circumference in predicting sarcopenia were 34 cm (sensitivity 67.1%, specificity 70.6%) in males, and 31 cm (sensitivity 82.5%, specificity 51.5%) in females. CONCLUSIONS: Even though sex differences in its predictive value for sarcopenia should be considered, our findings suggest that calf circumference can be used as an indicator for predicting muscle mass and may serve as a potential marker for identifying sarcopenia in older patients with chronic low back pain.


Subject(s)
Leg , Low Back Pain , Sarcopenia , Humans , Sarcopenia/diagnosis , Sarcopenia/epidemiology , Male , Female , Aged , Cross-Sectional Studies , Retrospective Studies , Low Back Pain/diagnosis , Low Back Pain/epidemiology , Chronic Pain/diagnosis , Chronic Pain/epidemiology , Muscle Strength/physiology , Aged, 80 and over , Predictive Value of Tests , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology
16.
BMJ Open ; 14(8): e082851, 2024 Aug 26.
Article in English | MEDLINE | ID: mdl-39187278

ABSTRACT

OBJECTIVE: To explore whether sedentary behaviour could modulate the association between overweight or obesity and chronic low back pain (CLBP). DESIGN: A retrospective cross-sectional study. SETTING AND PARTICIPANTS: A total of 4289 participants in the US cohort from the National Health and Nutrition Examination Survey were included. PRIMARY AND SECONDARY OUTCOME MEASURES: CLBP was the outcome. RESULTS: After adjusting for confounding factors, an increased risk of CLBP was identified in people who were overweight (OR 1.41, 95% CI 1.13 to 1.76) and obesity (OR 1.48, 95% CI 1.01 to 2.18). No significant association between sedentary behaviour time and CLBP was observed. In body mass index (BMI)<25 kg/m2 vs BMI≥30 kg/m2 group, sedentary behaviour time showed a modulatory effect on obesity and CLBP (p=0.047). In the sedentary behaviour time >4.5 hours group, the risk of CLBP was increased as BMI elevation, indicating sedentary behaviour time >4.5 hours played a modulatory role in the relationship between obesity and CLBP. CONCLUSION: Obesity was significantly associated with an increased risk of CLBP, and sedentary behaviour time modulated the association between obesity and CLBP. The findings might provide a reference for the lifestyle modifications among individuals with obesity and reducing sedentary behaviour is recommended for this population.


Subject(s)
Body Mass Index , Low Back Pain , Nutrition Surveys , Obesity , Sedentary Behavior , Humans , Cross-Sectional Studies , Low Back Pain/epidemiology , Obesity/epidemiology , Obesity/complications , Male , Female , Middle Aged , Retrospective Studies , Adult , United States/epidemiology , Chronic Pain/epidemiology , Risk Factors , Overweight/epidemiology , Aged
17.
Eur J Obstet Gynecol Reprod Biol ; 299: 317-321, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38959628

ABSTRACT

OBJECTIVE: Use clinical pain measurement tools to investigate and compare the prevalence of pelvic loin disoders in women with and without endometriosis. STUDY DESIGN: Chronic pelvic pain (CPP) associated with endometriosis has diverse origins, including musculoskeletal factors. Musculoskeletal dysfunction in the pelvic region is theorized to result from sustained muscular contraction, triggered by altered visceral stimuli and adoption of antalgic postures, causing secondary damage to muscles, ligaments, and joints. CPP significantly impacts quality of life, relationships, sexuality, and mental health. However, limited data exists on musculoskeletal impacts of endometriosis and CPP. It was made a case-control study at Maternidade Escola Assis Chateaubriand from August 2017 to January 2021. Evaluated 71 women: 41 in endometriosis group (EG) and 30 in control group (CG). Data collection included sociodemographic questionnaires, musculoskeletal physiotherapeutic evaluations, pain mapping, pressure pain thresholds, kinesiophobia, and disability measurements. Statistical analysis was performed using Spearman's Rho test to determine correlations. RESULTS: Mean age of participants was 31 years. EG exhibited lower pain threshold variations in lumbopelvic trigger points than CG (P < .05). Significant muscle flexibility differences between groups were observed; EG had reduced flexibility (P < .05). Most common pain areas were hypogastrium in EG (48.78 %) and left lumbar in CG (30 %). EG had higher kinesiophobia values (P = .009). There was a weak association between kinesiophobia-pressure threshold association observed in CG's lumbar pelvic region. CONCLUSION: Women with Endometriosis and CPP exhibit higher prevalence of musculoskeletal disorder, lower pain thresholds, decreased lumbopelvic muscle range of motion, higher kinesiophobia scores, and increased disability indices with low back pain compared to healthy women.


Subject(s)
Endometriosis , Pelvic Pain , Humans , Female , Endometriosis/complications , Endometriosis/physiopathology , Case-Control Studies , Adult , Pelvic Pain/epidemiology , Pelvic Pain/physiopathology , Pain Measurement , Chronic Pain/epidemiology , Chronic Pain/physiopathology , Pain Threshold , Young Adult
18.
Arthritis Res Ther ; 26(1): 138, 2024 Jul 25.
Article in English | MEDLINE | ID: mdl-39054458

ABSTRACT

OBJECTIVE: Define the prevalence and location of inflammatory and structural lesions on magnetic resonance imaging (MRI) in patients with rheumatoid arthritis (RA) and radiographic axial spondyloarthritis (r-axSpA) with neck pain as leading clinical symptom. METHODS: Patients with diagnosis of RA and r-axSpA were consecutively included if they had chronic (> 3 months) neck pain. Clinical assessment, neck pain questionnaires and MRIs of the cervical spine (CS) were performed. RESULTS: 107 patients (59 RA and 48 r-axSpA) were included. While there was no difference in the Northwick-Park-Neck-Pain-questionnaire, patients with RA reported higher neck pain compared to r-axSpA on a numeric rating scale (5.0 ± 3.6 vs. 3.0 ± 3.1; p = 0.003). Inflammatory lesions occurred predominantly in the craniocervical area in RA and in the lower CS segments in r-axSpA. Bone marrow edema (BME) was more frequent in axSpA (BME-score axSpA/RA: 0.35vs0.17; p < 0.001) while synovitis was visible in both but was more prevalent in RA (synovitis-score axSpA/RA: 0.02vs0.1; p < 0.001). BME was found in 8 (13.6%) vertebral corner vs. 9 (18.8%), in 2 (3.4%) facet joints vs. 7 (14.6%) and in 1 (1.7%) spinous processes vs. 9 (18.8%) in patients with RA/r-axSpA. In contrast, more patients with RA (30.5% vs6.3%) showed erosive osteochondrosis with endplate BME (p = 0.002). CONCLUSION: While involvement of upper cervical inflammation was typically present in RA, r-axSpA patients showed more BME in lower CS segments, vertebral corners, facet joints and spinous processes. Neck pain is linked to upper and lower inflammatory and structural lesions of the CS in both diseases.


Subject(s)
Arthritis, Rheumatoid , Axial Spondyloarthritis , Chronic Pain , Magnetic Resonance Imaging , Neck Pain , Humans , Female , Male , Arthritis, Rheumatoid/diagnostic imaging , Arthritis, Rheumatoid/complications , Magnetic Resonance Imaging/methods , Neck Pain/diagnostic imaging , Neck Pain/epidemiology , Neck Pain/etiology , Middle Aged , Prevalence , Adult , Chronic Pain/diagnostic imaging , Chronic Pain/etiology , Chronic Pain/epidemiology , Axial Spondyloarthritis/diagnostic imaging , Axial Spondyloarthritis/epidemiology , Cervical Vertebrae/diagnostic imaging , Radiography/methods , Aged , Inflammation/diagnostic imaging , Spondylarthritis/diagnostic imaging , Spondylarthritis/complications
19.
PLoS One ; 19(7): e0307992, 2024.
Article in English | MEDLINE | ID: mdl-39058752

ABSTRACT

BACKGROUND: Managing chronic pain was not only a major challenge but also a source of significant disability associated with mental illness. Studies on generalized anxiety disorder (GAD) in chronic pain population was rather limited. This study was aimed to determine the prevalence of GAD and its associated factors among patients attending a pain clinic at a general hospital. METHODS: This cross-sectional study recruited 201 patients. The Hospital Anxiety Depression Scale (HADS) was used to determine anxiety level. Subsequently, patients who had scored 8 and above on the HADS were interviewed using Mini International Neuropsychiatric Interview (M.I.N.I) to ascertain the diagnosis of GAD. Whilst the Numerical Rating Scale (NRS) assessed pain severity. Multiple logistic regression analysis was used to determine factors associated with GAD. RESULTS: Among those patients with chronic pain, the prevalence of GAD was 18.9%. Gender (AOR:7.94; 95% CI:2.34, 26.93), duration of the pain (AOR:1.30; 95% CI:1.03,1.63) and pain severity (AOR:18.75; CI:1.23,285.13) were significant factors associated with GAD. CONCLUSION: GAD is a prevalent condition among chronic pain patients.


Subject(s)
Anxiety Disorders , Chronic Pain , Humans , Male , Female , Chronic Pain/epidemiology , Chronic Pain/psychology , Cross-Sectional Studies , Middle Aged , Prevalence , Malaysia/epidemiology , Adult , Anxiety Disorders/epidemiology , Aged , Young Adult
20.
Article in English | MEDLINE | ID: mdl-38975684

ABSTRACT

BACKGROUND: It is unknown whether growth differentiation factor 15 (GDF-15) is associated with chronic musculoskeletal pain (CMP) and whether or not its association with incident cardiovascular disease (CVD) changes according to CMP status. METHODS: In total, 1 957 randomly selected adults aged ≥65 years without prior CVD were followed up between 2015 and 2023. CMP was classified according to its intensity, frequency, and interference with daily activities. The association between GDF-15 levels and CMP was assessed using linear models with progressive inclusion of potential confounders, whereas the association between GDF-15 and CVD risk was evaluated with Cox proportional hazard models with similar adjustment and interaction terms between GDF-15 and CMP. The incremental predictive performance of GDF-15 over standard predictors was evaluated using discrimination and risk reclassification metrics. RESULTS: GDF-15 concentrations were 6.90% (95% confidence interval [CI]: 2.56; 11.25) higher in individuals with CMP, and up to 8.89% (4.07; 15.71) and 15.79% (8.43; 23.16) higher in those with ≥3 CMP locations and interfering pain. These increased levels were influenced by a higher prevalence of cardiometabolic risk factors, functional impairments, depressive symptoms, and greater levels of inflammation in individuals with CMP. In fully adjusted models, a twofold increase in GDF-15 was associated with a 1.49 increased risk (95% CI: 1.08; 2.05) of a CVD event in individuals with CMP, but not among those without CMP (1.02 [0.77; 1.35]); p-interaction 0.041. Adding GDF-15 to models including the Framingham Risk Score improved predictive performance among individuals with CMP. CONCLUSIONS: We provide evidence that GDF-15 could serve as a biomarker to assess CMP, as well as to predict CVD incidence in individuals with CMP.


Subject(s)
Biomarkers , Cardiovascular Diseases , Chronic Pain , Growth Differentiation Factor 15 , Musculoskeletal Pain , Humans , Growth Differentiation Factor 15/blood , Male , Female , Musculoskeletal Pain/epidemiology , Musculoskeletal Pain/blood , Biomarkers/blood , Aged , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/blood , Chronic Pain/epidemiology , Chronic Pain/blood , Heart Disease Risk Factors , Risk Assessment/methods , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL